Foghorn Therapeutics's total assets for Q4 2024 were $283.98M, a decrease of -7.91% from the previous quarter. FHTX total liabilities were $329.51M for the fiscal quarter, a -2.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.